Gujarat Fluorochemicals FY24 Annual Earnings Summary
4 quarters covered · ₹4,281 Cr revenue · ₹435 Cr PAT · 22.0% average EBITDA margin.
Quarter-by-quarter progression
Management promises made during the year
Current-quarter commentary contains related risk or weakness, so the promise appears not to have been delivered yet.
Q2 FY24Current-quarter commentary contains related risk or weakness, so the promise appears not to have been delivered yet.
Q3 FY24Current-quarter commentary contains related risk or weakness, so the promise appears not to have been delivered yet.
Q3 FY24Risks flagged during the year
Destocking may persist longer than expected, delaying volume ramp-up and capacity utilization.
Q1 FY24 · highExcess Chinese capacity and slowdown in EV sector are pressuring PVDF prices and volumes.
Q2 FY24 · highContinued price pressure from Chinese and Russian competitors in commodity PTFE grades may persist, impacting margins.
Q4 FY24 · highAnalyst raised concern about high net debt-to-EBITDA (1.8x) and INR 800 crore CapEx; management confirmed external funding process but no guarantee.
Q1 FY24 · mediumWeak summer in domestic and overseas markets impacted refrigerant sales; Q2 expected to be similar to Q1.
Q1 FY24 · mediumApproval processes for battery-grade PVDF and semiconductor-grade PFA are taking longer than expected.
Q2 FY24 · mediumUS phase-out of R125 and circumvention issues have structurally impacted export volumes; recovery may be limited.
Q2 FY24 · mediumHigh-cost inventory led to gross margin compression; normalization may take another quarter.
Q2 FY24 · mediumDespite management's confidence, PFAS regulations in Europe and US could impact fluoropolymer demand if scope widens.
Q3 FY24 · mediumLegacy player inventory may take longer to deplete than expected, delaying volume recovery.
Q3 FY24 · mediumSpecialty chemical segment remains under pressure due to dumping from China, with no near-term improvement expected.
Q3 FY24 · mediumAnalyst raised concern about funding of EV CapEx and potential dilution; management deferred answer to separate EV call.
What changed through the year
Q1 FY24 · H2 FY24 improvement expected
Management expects business environment to pick up from Q3 onwards and normalize by end of FY24.
Q1 FY24 · CapEx of ₹1,500 crore may spill over
Planned CapEx for FY24 may not be fully incurred this year; some may spill into next fiscal.
Q1 FY24 · Battery chemicals commissioning in Q2 FY24
LiPF6 and electrolyte plants expected to come online by end of Q2 FY24, with meaningful revenue in FY25.
Q1 FY24 · EBITDA margin guidance of 28-33%
Management expects EBITDA margins to remain in the 28-33% range for the full year.
Q2 FY24 · FY25 revenue and profit to surpass FY23 levels
Management expects FY25 to be better than FY23, implying recovery to peak levels.
Q2 FY24 · 30% EBITDA margin target for FY25
Management reaffirms 30% EBITDA margin as normal run-rate, expecting to achieve it in FY25.
Q2 FY24 · H2 FY24 better than H1 FY24
Management expects gradual improvement in H2 due to destocking phasing out and legacy player exits.
Q2 FY24 · Battery chemical sampling to start shortly
Integrated LiPF6 and electrolyte plants are in advanced commissioning; customer sampling imminent.
Q3 FY24 · FY25 EBITDA at par with FY23
Management revised guidance: FY25 EBITDA will be at similar levels to FY23 (INR ~1,900 crore), not higher, with a possible quarter variance.
Q3 FY24 · CapEx for existing business at INR 500 crore in FY25
CapEx for non-EV business in FY25 will be around INR 500 crore, staggered from earlier plans.
Q3 FY24 · Fluoropolymer capacity ramp-up over next 4 quarters
New fluoropolymer capacity (1,800-1,900 TPM) will be utilized over the next four quarters as approvals and customer validations progress.
Q3 FY24 · Battery chemical revenue from H2 FY25
Revenue from battery chemicals (PVDF) expected to start from second half of FY25, with meaningful contribution from FY26.
Q4 FY24 · FY25 EBITDA to be similar to FY23 levels (~INR 1,800-1,900 crore)
Management expects EBITDA to recover to FY23 levels, driven by fluoropolymer volume growth and new capacity ramp-up.
Q4 FY24 · Battery chemical commercial sales from H2 FY25
LiPF6 plant commissioned; sampling and customer engagement underway. Revenue expected to start trickling in from second half of FY25.
Q4 FY24 · CapEx of INR 800 crore for battery chemicals in FY25
Funding to be raised externally; investment bankers appointed. CapEx plan remains on track.
Q4 FY24 · Fluoropolymer segment to see continuous growth in FY25
Green shoots visible; destocking phasing out. New capacities in FKM, PFA, PVDF, and micropowders to drive volume and value growth.